NO20003640L - New dosage form - Google Patents
New dosage formInfo
- Publication number
- NO20003640L NO20003640L NO20003640A NO20003640A NO20003640L NO 20003640 L NO20003640 L NO 20003640L NO 20003640 A NO20003640 A NO 20003640A NO 20003640 A NO20003640 A NO 20003640A NO 20003640 L NO20003640 L NO 20003640L
- Authority
- NO
- Norway
- Prior art keywords
- administered
- dosage unit
- food
- outer coating
- pharmaceutical
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 title 1
- 239000011248 coating agent Substances 0.000 abstract 4
- 238000000576 coating method Methods 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 4
- 229940079593 drug Drugs 0.000 abstract 2
- 239000002775 capsule Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 210000000813 small intestine Anatomy 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Dose-enhet med størrelse større enn 7 mm, som kan administreres oralt, omfattende et medikament og et ytre belegg som er utformet for å hindre frigivelse av medika- mentet i magen eller tynn-tarmen når den farmasøytiske dose-enheten er i nærvær av mat. Foreliggende oppfinnelse framskaffer videre en dose-enhet med størrelse større enn 7 mm, som kan administreres oralt, omfattende et medika- ment og et ytre belegg, hvor belegget er laget av et materiale som er løselig ved pH-verdier under 5,0 og egnet for å skille den farmasøytiske dose-enheten fra sam- administrert mat. Den farmasøytiske dose-enheten er fortrinnsvis i form av en belagt tablett eller kapsel. Det er fordelaktig om det ytre belegget er en polymer. I tillegg angår foreliggende oppfinnelse en framgangsmåte for å separere oralt administrerte dose-enheter fra sam- administrert mat, og bruk av nevnte farmasøytiske dose- enheter innen medisin.Dosage unit larger than 7 mm, which may be administered orally, comprising a drug and an outer coating designed to prevent release of the drug into the stomach or small intestine when the pharmaceutical dosage unit is in the presence of food. . The present invention further provides a dosage unit of size greater than 7 mm, which can be administered orally, comprising a medicament and an outer coating, wherein the coating is made of a material which is soluble at pH values below 5.0 and suitable to separate the pharmaceutical dose unit from co-administered food. The pharmaceutical dosage unit is preferably in the form of a coated tablet or capsule. It is advantageous if the outer coating is a polymer. In addition, the present invention relates to a method of separating orally administered dosage units from co-administered food, and the use of said pharmaceutical dosage units in medicine.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9801363.4A GB9801363D0 (en) | 1998-01-22 | 1998-01-22 | Novel dosage form |
| PCT/GB1999/000193 WO1999037290A1 (en) | 1998-01-22 | 1999-01-20 | Novel dosage form |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20003640D0 NO20003640D0 (en) | 2000-07-14 |
| NO20003640L true NO20003640L (en) | 2000-09-12 |
Family
ID=10825713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20003640A NO20003640L (en) | 1998-01-22 | 2000-07-14 | New dosage form |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1059918A1 (en) |
| JP (1) | JP2002501016A (en) |
| AR (1) | AR014467A1 (en) |
| AU (1) | AU2176099A (en) |
| CA (1) | CA2318257A1 (en) |
| GB (1) | GB9801363D0 (en) |
| NO (1) | NO20003640L (en) |
| WO (1) | WO1999037290A1 (en) |
| ZA (1) | ZA99454B (en) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9910773D0 (en) * | 1999-05-11 | 1999-07-07 | West Pharm Serv Drug Res Ltd | Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract |
| GB0102342D0 (en) * | 2001-01-30 | 2001-03-14 | Smithkline Beecham Plc | Pharmaceutical formulation |
| WO2006020009A1 (en) * | 2004-07-23 | 2006-02-23 | The Procter & Gamble Company | Solid oral dosage form of a bisphosphonate containing a chelating agent |
| US8836513B2 (en) | 2006-04-28 | 2014-09-16 | Proteus Digital Health, Inc. | Communication system incorporated in an ingestible product |
| US9198608B2 (en) | 2005-04-28 | 2015-12-01 | Proteus Digital Health, Inc. | Communication system incorporated in a container |
| US8802183B2 (en) | 2005-04-28 | 2014-08-12 | Proteus Digital Health, Inc. | Communication system with enhanced partial power source and method of manufacturing same |
| US8912908B2 (en) | 2005-04-28 | 2014-12-16 | Proteus Digital Health, Inc. | Communication system with remote activation |
| EP2671508B1 (en) | 2005-04-28 | 2020-09-16 | Proteus Digital Health, Inc. | Pharma-informatics system |
| CN105468895A (en) | 2006-05-02 | 2016-04-06 | 普罗透斯数字保健公司 | Patient customized therapeutic regimens |
| US8945005B2 (en) | 2006-10-25 | 2015-02-03 | Proteus Digital Health, Inc. | Controlled activation ingestible identifier |
| EP2069004A4 (en) | 2006-11-20 | 2014-07-09 | Proteus Digital Health Inc | Active signal processing personal health signal receivers |
| CA2676407A1 (en) | 2007-02-01 | 2008-08-07 | Proteus Biomedical, Inc. | Ingestible event marker systems |
| EP3236524A1 (en) | 2007-02-14 | 2017-10-25 | Proteus Digital Health, Inc. | In-body power source having high surface area electrode |
| US9270025B2 (en) | 2007-03-09 | 2016-02-23 | Proteus Digital Health, Inc. | In-body device having deployable antenna |
| WO2008112577A1 (en) | 2007-03-09 | 2008-09-18 | Proteus Biomedical, Inc. | In-body device having a multi-directional transmitter |
| US8115618B2 (en) | 2007-05-24 | 2012-02-14 | Proteus Biomedical, Inc. | RFID antenna for in-body device |
| PT2192946T (en) | 2007-09-25 | 2022-11-17 | Otsuka Pharma Co Ltd | In-body device with virtual dipole signal amplification |
| WO2009070773A1 (en) | 2007-11-27 | 2009-06-04 | Proteus Biomedical, Inc. | Transbody communication systems employing communication channels |
| JP2011513865A (en) | 2008-03-05 | 2011-04-28 | プロテウス バイオメディカル インコーポレイテッド | Multi-mode communication ingestible event marker and system and method of using the same |
| KR101615128B1 (en) | 2008-07-08 | 2016-04-26 | 프로테우스 디지털 헬스, 인코포레이티드 | Ingestible event marker data framework |
| US8540633B2 (en) | 2008-08-13 | 2013-09-24 | Proteus Digital Health, Inc. | Identifier circuits for generating unique identifiable indicators and techniques for producing same |
| JP2012514799A (en) | 2009-01-06 | 2012-06-28 | プロテウス バイオメディカル インコーポレイテッド | Methods and systems for ingestion related biofeedback and individual pharmacotherapy |
| US8540664B2 (en) | 2009-03-25 | 2013-09-24 | Proteus Digital Health, Inc. | Probablistic pharmacokinetic and pharmacodynamic modeling |
| SG10201810784SA (en) | 2009-04-28 | 2018-12-28 | Proteus Digital Health Inc | Highly Reliable Ingestible Event Markers And Methods For Using The Same |
| US9149423B2 (en) | 2009-05-12 | 2015-10-06 | Proteus Digital Health, Inc. | Ingestible event markers comprising an ingestible component |
| TWI517050B (en) | 2009-11-04 | 2016-01-11 | 普羅托斯數位健康公司 | System for supply chain management |
| MX2012011693A (en) | 2010-04-07 | 2013-02-15 | Proteus Digital Health Inc | Miniature ingestible device. |
| TWI557672B (en) | 2010-05-19 | 2016-11-11 | 波提亞斯數位康健公司 | Computer system and computer-implemented method to track medication from manufacturer to a patient, apparatus and method for confirming delivery of medication to a patient, patient interface device |
| WO2012071280A2 (en) | 2010-11-22 | 2012-05-31 | Proteus Biomedical, Inc. | Ingestible device with pharmaceutical product |
| WO2015112603A1 (en) | 2014-01-21 | 2015-07-30 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
| US9756874B2 (en) | 2011-07-11 | 2017-09-12 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
| BR112014001397A2 (en) | 2011-07-21 | 2017-02-21 | Proteus Biomedical Inc | device, system and method of mobile communication |
| US9235683B2 (en) | 2011-11-09 | 2016-01-12 | Proteus Digital Health, Inc. | Apparatus, system, and method for managing adherence to a regimen |
| KR20150038038A (en) | 2012-07-23 | 2015-04-08 | 프로테우스 디지털 헬스, 인코포레이티드 | Techniques for manufacturing ingestible event markers comprising an ingestible component |
| DK2910013T3 (en) | 2012-10-18 | 2018-08-06 | Proteus Digital Health Inc | Apparatus, system and method for adaptive optimization for power output and transmit power in a power source for a communication device |
| TWI659994B (en) | 2013-01-29 | 2019-05-21 | 美商普羅托斯數位健康公司 | Highly-swellable polymeric films and compositions comprising the same |
| WO2014144738A1 (en) | 2013-03-15 | 2014-09-18 | Proteus Digital Health, Inc. | Metal detector apparatus, system, and method |
| US11744481B2 (en) | 2013-03-15 | 2023-09-05 | Otsuka Pharmaceutical Co., Ltd. | System, apparatus and methods for data collection and assessing outcomes |
| US9796576B2 (en) | 2013-08-30 | 2017-10-24 | Proteus Digital Health, Inc. | Container with electronically controlled interlock |
| US10084880B2 (en) | 2013-11-04 | 2018-09-25 | Proteus Digital Health, Inc. | Social media networking based on physiologic information |
| US11051543B2 (en) | 2015-07-21 | 2021-07-06 | Otsuka Pharmaceutical Co. Ltd. | Alginate on adhesive bilayer laminate film |
| CN109843149B (en) | 2016-07-22 | 2020-07-07 | 普罗秋斯数字健康公司 | Electromagnetic sensing and detection of ingestible event markers |
| KR102605670B1 (en) | 2016-10-26 | 2023-11-24 | 오츠카 세이야쿠 가부시키가이샤 | Methods for manufacturing capsules with ingestible event markers |
| US11458104B1 (en) * | 2018-06-21 | 2022-10-04 | Mission Pharmacal Company | Enteric coated tiopronin tablet |
| CN109453166B (en) * | 2018-10-16 | 2021-03-12 | 丹诺医药(苏州)有限公司 | Solid dispersion of rifamycin-quinolizinone coupled molecules and application thereof |
| CN110613697A (en) * | 2019-10-30 | 2019-12-27 | 长春迪瑞制药有限公司 | Cefalexin capsule and preparation method thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4786508A (en) * | 1986-05-30 | 1988-11-22 | Warner-Lambert Company | Coated dosage forms |
| FR2618331B1 (en) * | 1987-07-23 | 1991-10-04 | Synthelabo | PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF UREMIA |
| NZ228557A (en) * | 1988-04-05 | 1990-11-27 | Kyowa Hakko Kogyo Kk | Coating agent for delaying the release of active agents to be administered per os to ruminants, and veterinary compositions |
-
1998
- 1998-01-22 GB GBGB9801363.4A patent/GB9801363D0/en not_active Ceased
-
1999
- 1999-01-20 CA CA002318257A patent/CA2318257A1/en not_active Abandoned
- 1999-01-20 EP EP99901758A patent/EP1059918A1/en not_active Withdrawn
- 1999-01-20 JP JP2000528272A patent/JP2002501016A/en active Pending
- 1999-01-20 WO PCT/GB1999/000193 patent/WO1999037290A1/en not_active Ceased
- 1999-01-20 AU AU21760/99A patent/AU2176099A/en not_active Abandoned
- 1999-01-21 ZA ZA9900454A patent/ZA99454B/en unknown
- 1999-01-22 AR ARP990100264A patent/AR014467A1/en unknown
-
2000
- 2000-07-14 NO NO20003640A patent/NO20003640L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR014467A1 (en) | 2001-02-28 |
| ZA99454B (en) | 2000-10-23 |
| JP2002501016A (en) | 2002-01-15 |
| AU2176099A (en) | 1999-08-09 |
| NO20003640D0 (en) | 2000-07-14 |
| CA2318257A1 (en) | 1999-07-29 |
| WO1999037290A1 (en) | 1999-07-29 |
| EP1059918A1 (en) | 2000-12-20 |
| GB9801363D0 (en) | 1998-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR014467A1 (en) | ORMALLY ADMINISTRABLE PHARMACEUTICAL DOSE UNIT OF A SIZE HIGHER THAN 7 MM THAT INCLUDES A DRUG AND EXTERNAL COATING, A METHOD TO PARASEPAR AN ORALLY ADMINISTRABLE PHARMACEUTICAL DOSE UNIT FROM A DIFFERENT CO-ADMINISTRATED FOOD AND USE COVER | |
| EP1595538A3 (en) | Modified release tamsulosin tablets | |
| CA2144094A1 (en) | Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract | |
| JP3633936B2 (en) | Senna dosage form | |
| AU4334700A (en) | Pharmaceutical dosage form for pulsatile delivery of methylphenidate | |
| BG104317A (en) | Method for the treatment of capsules and dry, powder pharmaceutical forms | |
| MX9500885A (en) | Pharmaceutical preparation for oral administration. | |
| CA2181502A1 (en) | Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract | |
| IL211075A (en) | Multiparticulate modified release composition | |
| CA2601289A1 (en) | Once-a-day oxycodone formulations | |
| JP2006016395A (en) | Pharmaceutical formulation for safe administration of drug used for treatment of drug dependency and method for obtaining pharmaceutical formulation | |
| CA2383250A1 (en) | Phytochemicals for treatment of mastalgia and endometriosis | |
| TWI241195B (en) | Preventive agent for bile acidic diarrhea | |
| AR018582A1 (en) | DOSAGE FORM IN TABLET TO ADMINISTER AN ANTAGONIST OF THE LEUCOTRIEN RECEPTORS AND THEIR USE IN THE PREPARATION OF MEDICINES | |
| EP1217992A1 (en) | Coated solid dosage forms | |
| Namdev et al. | Floating Drug Delivery Systems: An emerging trend for the treatment of peptic ulcer | |
| SA520411808B1 (en) | Deferiprone delayed-release tablets and methods for their use | |
| JPH0624959A (en) | Gastric floating type sustained release solid formulation | |
| CA2383212A1 (en) | Controlled release oral dosage suitable for oral administration | |
| KR900015724A (en) | Maveline capacity form | |
| DK165123B (en) | PROCEDURE FOR MECHANICAL WORKING OF COBALT-CONTAINING METALS AND WATER MIXABLE CONCENTRATE FOR USE IN THE PROCEDURE | |
| US5082665A (en) | Anti-snoring formulations using yohimbine | |
| WO2007086079A3 (en) | Sustained release dosage form of phenothiazine derivatives containing channelizer | |
| RU2000114174A (en) | APPLICATION OF PHOSPHOLIPID COMPLEXES OF EXTRACTS FROM VITIS VINIFERA AS ANTIATHEROSCLEROTIC AGENTS | |
| PL1643999T3 (en) | Pyridoxamine for use in the treatment of diabetic neprhopathy in type ii diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |